Aditxt Resolves Nasdaq Delisting Risk, Regains Compliance with $3.95M Equity
Summary
Aditxt, Inc. has successfully regained compliance with Nasdaq's minimum stockholders' equity rule, reporting $3.95 million in stockholders' equity. This positive development resolves a significant delisting risk that was explicitly highlighted in the company's recent 10-K filing on March 31st and was the subject of a proposed reverse stock split in a PRE 14A on March 24th. The company had previously received a noncompliance notification from Nasdaq on December 1, 2025. Regaining compliance removes a major overhang and uncertainty for the stock, which had been facing potential delisting. While this specific compliance issue is now closed, the company's recent 10-K also raised "substantial doubt about its ability to continue as a going concern" and disclosed material weaknesses in internal controls. Traders will continue to monitor future financial performance and operational stability for further indications of the company's long-term viability.
At the time of this announcement, ADTX was trading at $0.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $466K. The 52-week trading range was $0.76 to $5,214.68. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.